timolol has been researched along with carteolol in 67 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (23.88) | 18.7374 |
1990's | 25 (37.31) | 18.2507 |
2000's | 19 (28.36) | 29.6817 |
2010's | 3 (4.48) | 24.3611 |
2020's | 4 (5.97) | 2.80 |
Authors | Studies |
---|---|
Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Baba, H; Tokoro, T; Yamazaki, S | 1 |
Allen, RC; Bahr, RL; Cohen, JS; Delehanty, JT; Hetherington, JN; Hoskins, HD; Lewis, RA; Noblin, JE; Shields, MB; Stewart, WC | 1 |
Hugues, FC; Le Jeunne, C; Munera, Y | 1 |
Bringer, L; Dufier, JL; Hugues, FC; Le Jeunne, CL; Munera, Y | 1 |
Collignon-Brach, J | 1 |
James, IM | 1 |
Pillunat, LE; Stodtmeister, R | 1 |
Finger, B; Neubrand, M; Pillunat, L; Stodtmeister, R; Tobias, G; Wilmanns, I | 1 |
Awata, T; Fukuda, M; Ishii, Y; Matsuda, M | 1 |
Nagai, T; Nishiyama, K; Segawa, K; Tanaka, N | 1 |
Berlin, I; Le Hoang, P; Marcel, P; Millon, D; Puech, AJ; Uzzan, B | 1 |
Schnarr, KD | 1 |
Hugues, FC; Le Jeunne, C; Munera, Y; Teillet, L | 1 |
Duff, GR; Newcombe, RG | 1 |
Krieglstein, GK; Mueller, B; Scoville, B; White, BG | 1 |
Brazier, DJ; Smith, SE | 1 |
Flury, H; Martenet, AC; Tournoux, A | 1 |
Krieglstein, GK; Scoville, B; Then, E; Yokoyama, S; Yokoyama, T | 1 |
Cunliffe, I; McIntyre, C; Rees, R; Rennie, I | 1 |
Allaire, C; Dascotte, JC; George, JL; Khaitrine, L; Lesure, P; Nordmann, JP; Rouland, JF; Sirbat, D; Trinquand, C | 1 |
Zimmerman, TJ | 1 |
Becker, EJ; Chen, Z; DeSantis, L; Hester, RK; McLaughlin, M | 1 |
Frishman, WH; Fuksbrumer, MS; Tannenbaum, M | 1 |
James, R; Pometta, D; Safran, AB; Sansonetti, A; Simona, F | 1 |
Freedman, NJ; Freedman, SF; Keates, EU; Lobaugh, B; Ollie, A; Samsa, GP; Shields, MB | 1 |
Carr, RD; Humphries, RG; Millar, JC; Wilson, WS | 1 |
Ando, Y; Goto, Y; Hayakawa, T; Ichien, M; Ido, T; Inazumi, K; Kato, A; Kitazawa, Y; Maeda, S; Noma, A; Yamamoto, T | 1 |
Cassels-Brown, A; Diggory, P; Fernandez, C | 1 |
Hong, SJ; Wang, HZ; Wu, KY | 2 |
Ichikawa, M; Kawakami, S; Mukai, T; Nakamura, J; Nishida, K; Sasaki, H; Yamamura, K | 1 |
Cohen, JS; Netland, PA; Nussbaum, LL; Stewart, WC; Weiss, HS | 1 |
Cohen, JS; Netland, PA; Nussbaum, LL; Stewart, WC; Weiss, H | 1 |
Araie, M; Nagahara, M; Tamaki, Y; Tomidokoro, A; Tomita, K | 1 |
Fukuda, S; Kanda, Y; Kiuchi, Y; Koide, R; Oguchi, K; Ohtori, R; Sato, H; Ueda, T | 1 |
Bazex, J; Calix, I; Giordano-Labadie, F; Lepoittevin, JP | 1 |
Apostolaros, M; Dubiner, HB; Hudgins, AC; Katz, LJ; Laibovitz, RA; Mundorf, TK; Nussbaum, L; Sall, KN; Shulman, DG; Siegel, LI; Singh, K; Stewart, WC | 1 |
Araie, M; Muta, K; Tamaki, Y; Tomidokoro, A | 1 |
Hayashi, E; Hayashi-Morimoto, R; Ishikawa, H; Sato, Y; Yoshitomi, T | 1 |
Melena, J; Osborne, NN; Wood, JP | 1 |
Bartlett, JD; Olivier, M; Pensyl, D; Richardson, T; Whitaker, R; Wilson, MR | 1 |
Karaküçük, S; Mirza, GE; Temel, E | 1 |
de San Pedro, BS; Florido, F; Quiralte, J | 1 |
Chidlow, G; Melena, J; Osborne, NN | 1 |
Kijlstra, A; Mulder, M; van Beek, LM; van Haeringen, NJ | 1 |
Iga, T; Ito, K; Ohtani, H; Sawada, Y; Takayanagi, R; Tsuchiya, K; Yamada, Y | 1 |
Barnett, MF; Haybittle, J; Parker, V; Watson, PG | 1 |
Baudouin, C; De Saint Jean, M; Debbasch, C; Pisella, PJ; Rat, P; Warnet, JM | 1 |
Belcaro, GV; Cesarone, MR; De Sanctis, MT; Incandela, L; Laurora, G; Minicucci, R; Steigerwalt, RD | 1 |
Ishibashi, Y; Muto, T; Roy, S; Sato, T | 1 |
Clark, JI; Martin, RW; Vaezy, S; Zderic, V | 1 |
Fong, JC; Hong, SJ; Wang, HZ; Wu, KY | 1 |
Baudouin, C; Blondin, C; Cholley, B; Haeffner-Cavaillon, N; Hamard, P | 1 |
Amano, S; Inoue, K; Inoue, Y; Kato, S; Okugawa, K; Oshika, T; Tomita, G | 1 |
Baudouin, C; Bron, AM; Creuzot-Garcher, C; Lizard, G; Malvitte, L; Montange, T; Vejux, A | 1 |
Ikeda, T; Ishida, O; Kojima, S; Sugiyama, T | 1 |
Daito, M; Hiraoka, T; Kiuchi, T; Okamoto, F; Oshika, T | 1 |
Akaishi, T; Fuwa, M; Kato, M; Mieda, M; Shimazaki, A; Taniguchi, T; Yamashita, N | 1 |
Jolobe, OMP | 1 |
Barbeau, M; Beauchemin, C; Cui, AX; Harasymowycz, P; Jobin-Gervais, K; Lachaine, J; Mathurin, K; Royer, C | 1 |
Aihara, M; Kishimoto, N; Kizaki, J; Saito, Y; Shibasaki, Y; Wada, Y | 1 |
Chang, WC; Chen, A; Chiang, WY; Hsu, MC; Kuo, MT; Lin, YA | 1 |
5 review(s) available for timolol and carteolol
Article | Year |
---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
Pharmacologic effects of beta-blocking agents used in the management of glaucoma.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Heart Rate; Humans; Intraocular Pressure; Levobunolol; Metipranolol; Propanolamines; Solubility; Timolol | 1989 |
Topical ophthalmic beta blockers: a comparative review.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Carteolol; Drug Tolerance; Glaucoma; Humans; Intraocular Pressure; Levobunolol; Metipranolol; Ophthalmic Solutions; Timolol | 1993 |
Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Humans; Levobunolol; Metipranolol; Ocular Hypertension; Timolol | 1994 |
Short-term efficacy of latanoprostene bunod for the treatment of open-angle glaucoma and ocular hypertension: a systematic literature review and a network meta-analysis.
Topics: Amides; Antihypertensive Agents; Bayes Theorem; Betaxolol; Bimatoprost; Brimonidine Tartrate; Carteolol; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Network Meta-Analysis; Ocular Hypertension; Prostaglandins A; Prostaglandins F, Synthetic; Timolol; Travoprost | 2022 |
22 trial(s) available for timolol and carteolol
Article | Year |
---|---|
A 3-month comparison of 1% and 2% carteolol and 0.5% timolol in open-angle glaucoma.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Blood Pressure; Carteolol; Dosage Forms; Double-Blind Method; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Timolol | 1991 |
Systemic effects of three beta-blocker eyedrops: comparison in healthy volunteers of beta 1- and beta 2-adrenoreceptor inhibition.
Topics: Adrenergic beta-Antagonists; Adult; Betaxolol; Carteolol; Female; Heart Rate; Humans; Isoproterenol; Male; Muscle, Smooth, Vascular; Myocardium; Ophthalmic Solutions; Randomized Controlled Trials as Topic; Timolol | 1990 |
Early visual field changes with beta-blocking agents.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Drug Evaluation, Preclinical; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Propanolamines; Timolol; Visual Fields | 1989 |
[Effect of carteolol and timolol eyedrops on the pressure tolerance of the optic nerve head].
Topics: Adaptation, Physiological; Adult; Carteolol; Double-Blind Method; Female; Humans; Intraocular Pressure; Male; Ophthalmic Solutions; Optic Disk; Propanolamines; Random Allocation; Timolol; Vision, Ocular | 1989 |
A single dose of three different ophthalmic beta-blockers antagonizes the chronotropic effect of isoproterenol in healthy volunteers.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Carteolol; Double-Blind Method; Heart Rate; Humans; Intraocular Pressure; Isoproterenol; Male; Metipranolol; Ophthalmic Solutions; Random Allocation; Timolol | 1987 |
The 12-hour control of intraocular pressure on carteolol 2% twice daily.
Topics: Aged; Aged, 80 and over; Carteolol; Clinical Trials as Topic; Double-Blind Method; Female; Glaucoma; Humans; Intraocular Pressure; Male; Middle Aged; Propanolamines; Timolol | 1988 |
A double-masked comparison of carteolol and timolol in ocular hypertension.
Topics: Administration, Topical; Ambulatory Care; Carteolol; Clinical Trials as Topic; Drug Administration Schedule; Humans; Intraocular Pressure; Ocular Hypertension; Ophthalmic Solutions; Propanolamines; Timolol | 1988 |
Ocular and cardiovascular response to topical carteolol 2% and timolol 0.5% in healthy volunteers.
Topics: Adult; Blood Pressure; Cardiovascular System; Carteolol; Depression, Chemical; Double-Blind Method; Female; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Physical Exertion; Propanolamines; Timolol | 1988 |
[Tolerance and pharmacologic effectiveness of antiglaucoma eyedrops].
Topics: Adult; Aged; Carteolol; Double-Blind Method; Female; Glaucoma; Glaucoma, Open-Angle; Heart Rate; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Propanolamines; Timolol | 1986 |
Measuring drug-induced eye irritation: a simple new clinical assay.
Topics: Blood Pressure; Carteolol; Endophthalmitis; Humans; Male; Ophthalmic Solutions; Pulse; Time Factors; Timolol | 1985 |
[Hypotensive action of 0.5% carteolol versus 0.1% timolol in patients with intraocular hypertension].
Topics: Adult; Carteolol; Double-Blind Method; Female; Humans; Male; Ocular Hypertension; Prospective Studies; Timolol | 1995 |
Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level.
Topics: Administration, Topical; Adult; Carteolol; Cholesterol; Cholesterol, HDL; Double-Blind Method; Eye; Humans; Intraocular Pressure; Lipids; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Timolol | 1993 |
The effects of the beta-adrenergic-blocking agents, timolol and carteolol, on plasma lipids and lipoproteins in Japanese glaucoma patients.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carteolol; Cholesterol; Cholesterol, HDL; Female; Glaucoma, Open-Angle; Humans; Lipids; Lipoproteins; Male; Middle Aged; Ocular Hypertension; Phosphatidylcholine-Sterol O-Acyltransferase; Prospective Studies; Timolol | 1996 |
Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Airway Resistance; Betaxolol; Blood Pressure; Carteolol; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Pulse; Spirometry; Sympathomimetics; Timolol | 1996 |
Cardiovascular effects of topical carteolol hydrochloride and timolol maleate in patients with ocular hypertension and primary open-angle glaucoma. Night Study Group.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carteolol; Double-Blind Method; Female; Glaucoma, Open-Angle; Heart Rate; Humans; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Timolol; Visual Acuity | 1997 |
Efficacy of carteolol hydrochloride 1% vs timolol maleate 0.5% in patients with increased intraocular pressure. Nocturnal Investigation of Glaucoma Hemodynamics Trial Study Group.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Aged, 80 and over; Carteolol; Double-Blind Method; Female; Humans; Intraocular Pressure; Male; Middle Aged; Ocular Hypertension; Timolol; Treatment Outcome | 1997 |
Effects of carteolol and timolol on plasma lipid profiles in older women with ocular hypertension or primary open-angle glaucoma.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Carteolol; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Lipids; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies; Timolol | 1999 |
Central nervous system and plasma lipid profiles associated with carteolol and timolol in postmenopausal black women.
Topics: Adrenergic beta-Antagonists; Aged; Black People; Brain; Carteolol; Double-Blind Method; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lipids; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Postmenopause; Timolol; Visual Acuity | 1999 |
Comparison of the effects of 0.5% timolol maleate, 2% carteolol hydrochloride, and 0.3% metipranolol on intraocular pressure and perimetry findings and evaluation of their ocular and systemic effects.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Carteolol; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Lipids; Male; Metipranolol; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Timolol; Treatment Outcome; Visual Field Tests; Visual Fields | 2000 |
A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
Topics: Adrenergic beta-Antagonists; Aged; Betaxolol; Carteolol; Drug Therapy, Combination; Female; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Linear Models; Male; Prospective Studies; Survival Analysis; Timolol; Trabeculectomy; Treatment Outcome; Visual Fields | 2001 |
Changes in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Aged; Blood Flow Velocity; Blood Pressure; Carteolol; Ciliary Arteries; Cross-Over Studies; Drug Therapy, Combination; Female; Humans; Intraocular Pressure; Laser-Doppler Flowmetry; Latanoprost; Low Tension Glaucoma; Male; Middle Aged; Ophthalmic Artery; Ophthalmic Solutions; Optic Disk; Prostaglandins F, Synthetic; Regional Blood Flow; Retinal Artery; Timolol; Tonometry, Ocular | 2009 |
Comparison of the 24-h efficacy and safety of fixed combination carteolol/latanoprost and timolol/latanoprost in patients with primary open-angle glaucoma and ocular hypertension: a prospective crossover study.
Topics: Antihypertensive Agents; Carteolol; Cross-Over Studies; Drug Combinations; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Latanoprost; Ocular Hypertension; Prospective Studies; Prostaglandins F, Synthetic; Timolol; Treatment Outcome | 2021 |
40 other study(ies) available for timolol and carteolol
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
[Effects of timolol and carteolol on ocular pulsatile blood flow].
Topics: Adult; Carteolol; Eye; Humans; Intraocular Pressure; Pulsatile Flow; Regional Blood Flow; Timolol | 1992 |
Bronchial and cardiovascular effects of ocular topical B-antagonists in asthmatic subjects: comparison of timolol, carteolol, and metipranolol.
Topics: Adrenergic beta-Antagonists; Asthma; Carteolol; Female; Forced Expiratory Volume; Hemodynamics; Humans; Male; Metipranolol; Ophthalmic Solutions; Timolol; Vital Capacity | 1989 |
Pressure compliance test of the optic nerve head: influence of different antiglaucoma drugs.
Topics: Acetazolamide; Adrenergic beta-Antagonists; Betaxolol; Carteolol; Glaucoma; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Optic Disk; Pilocarpine; Propanolamines; Timolol | 1989 |
The effect of long-term topical administration of commercial beta-blockers on the rat corneal endothelium.
Topics: Administration, Topical; Animals; Carteolol; Endothelium, Corneal; Longitudinal Studies; Male; Microscopy; Propanolamines; Random Allocation; Rats; Rats, Inbred Strains; Time Factors; Timolol | 1989 |
Effects of three beta-blocker eye drops on the rabbit cornea: an electron microscope study.
Topics: Adrenergic beta-Antagonists; Animals; Carteolol; Cornea; Microscopy, Electron; Propanolamines; Rabbits; Timolol | 1986 |
[Comparative multicenter study of carteolol eyedrops with other beta blockers in 768 patients under normal conditions].
Topics: Adrenergic beta-Antagonists; Carteolol; Drug Evaluation; Glaucoma; Humans; Intraocular Pressure; Metipranolol; Ophthalmic Solutions; Pindolol; Propanolamines; Time Factors; Timolol | 1988 |
[Asthma and beta-blocker eye drops (timolol, metipranolol, carteolol). Inhibition of chronotropic effects of isoprenaline].
Topics: Adult; Asthma; Blood Pressure; Carteolol; Heart Rate; Humans; Isoproterenol; Metipranolol; Middle Aged; Ophthalmic Solutions; Propanolamines; Respiration; Timolol | 1988 |
The effect of topical beta-blocker medications on the proliferation and viability of human Tenon's capsule fibroblasts in tissue culture.
Topics: Adrenergic beta-Antagonists; Benzalkonium Compounds; Carteolol; Cell Division; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Eye; Fascia; Fibroblasts; Humans; Levobunolol; Ophthalmic Solutions; Timolol | 1995 |
The direct vascular relaxing action of betaxolol, carteolol and timolol in porcine long posterior ciliary artery.
Topics: Animals; Arteries; Betaxolol; Calcium; Carteolol; Ciliary Body; Iliac Artery; Muscle, Smooth, Vascular; Nitroprusside; Rabbits; Swine; Timolol; Vasoconstriction | 1994 |
Effects of ocular carteolol and timolol on plasma high-density lipoprotein cholesterol level.
Topics: Carteolol; Cholesterol, HDL; Humans; Ophthalmic Solutions; Timolol; Triglycerides | 1994 |
Drug effects on intraocular pressure and vascular flow in the bovine perfused eye using radiolabelled microspheres.
Topics: Adrenergic beta-Antagonists; Animals; Blood Flow Velocity; Carteolol; Cattle; Cerium Radioisotopes; Choroid; Ciliary Body; Eye; Intraocular Pressure; Iris; Microspheres; Nitroprusside; Perfusion; Regional Blood Flow; Timolol; Vasodilator Agents; Verapamil | 1995 |
Effects of pilocarpine and other antiglaucoma drugs on cultured human Tenon's fibroblast cells.
Topics: Adrenergic beta-Antagonists; Betaxolol; Carteolol; Cell Division; Cells, Cultured; Eye; Fibroblasts; Glaucoma; Humans; Levobunolol; Muscarinic Agonists; Pilocarpine; Thymidine; Timolol | 1997 |
In-situ ocular absorption of ophthalmic beta-blockers through ocular membranes in albino rabbits.
Topics: Absorption; Adrenergic beta-Antagonists; Animals; Carteolol; Conjunctiva; Cornea; Eye; Male; Propanolamines; Rabbits; Sclera; Timolol | 1997 |
Effect of topical beta-blockers on tissue blood flow in the human optic nerve head.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Adult; Blood Flow Velocity; Blood Pressure; Carteolol; Heart Rate; Humans; Intraocular Pressure; Laser-Doppler Flowmetry; Ophthalmic Solutions; Optic Disk; Regional Blood Flow; Reproducibility of Results; Timolol | 1997 |
Pharmacokinetics of topical beta-adrenergic antagonists in rabbit aqueous humor evaluated with the microdialysis method.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Aqueous Humor; Carteolol; Chromatography, High Pressure Liquid; Rabbits; Time Factors; Timolol | 1998 |
[Contact allergy to beta blockaders in eye drops: cross allergy?].
Topics: Adrenergic beta-Antagonists; Aged; Carteolol; Cross Reactions; Dermatitis, Contact; Eyelid Diseases; Glaucoma; Humans; Male; Ophthalmic Solutions; Propanolamines; Skin Tests; Timolol | 1997 |
Effects of topical carteolol and timolol on tissue circulation in the iris and choroid.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Blood Circulation; Blood Flow Velocity; Carteolol; Choroid; Intraocular Pressure; Iris; Rabbits; Time Factors; Timolol; Vascular Resistance | 1999 |
Effects of beta antagonists on mechanical properties in rabbit ciliary artery.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Betaxolol; Carteolol; Cholinergic Agonists; Ciliary Arteries; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoproterenol; Male; Muscle, Smooth, Vascular; Phenylephrine; Rabbits; Receptors, Adrenergic, alpha-1; Timolol; Vasoconstriction | 1999 |
Betaxolol, a beta1-adrenoceptor antagonist, has an affinity for L-type Ca2+ channels.
Topics: Adrenergic beta-Antagonists; Animals; Betaxolol; Binding, Competitive; Calcium Channels; Carteolol; Cerebral Cortex; Diltiazem; Dose-Response Relationship, Drug; Female; Male; Membranes; Nitrendipine; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Stereoisomerism; Timolol; Tritium | 1999 |
Allergic contact dermatitis from carteolol and timolol in eyedrops.
Topics: Adrenergic beta-Antagonists; Carteolol; Cross Reactions; Dermatitis, Allergic Contact; Drug Eruptions; Eyelids; Glaucoma, Open-Angle; Humans; Male; Middle Aged; Ophthalmic Solutions; Patch Tests; Prognosis; Timolol | 2000 |
Betaxolol, a beta(1)-adrenoceptor antagonist, reduces Na(+) influx into cortical synaptosomes by direct interaction with Na(+) channels: comparison with other beta-adrenoceptor antagonists.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Batrachotoxins; Betaxolol; Binding, Competitive; Carteolol; Cerebral Cortex; Dose-Response Relationship, Drug; Kinetics; Levobunolol; Membranes; Propranolol; Rats; Rats, Wistar; Saxitoxin; Sodium; Sodium Channels; Sodium Radioisotopes; Synaptosomes; Timolol; Tritium | 2000 |
Topical ophthalmic beta blockers may cause release of histamine through cytotoxic effects on inflammatory cells.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Basophils; Betaxolol; Carteolol; Cells, Cultured; Dose-Response Relationship, Drug; Histamine Release; Humans; L-Lactate Dehydrogenase; Leukocytes; Metipranolol; Timolol | 2000 |
Assessment of systemic adverse reactions induced by ophthalmic beta-adrenergic receptor antagonists.
Topics: Administration, Oral; Administration, Topical; Adrenergic beta-Antagonists; Betaxolol; Cardiovascular Diseases; Carteolol; Exercise; Forced Expiratory Volume; Heart; Heart Rate; Humans; Lung; Ophthalmic Solutions; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Respiration Disorders; Retrospective Studies; Timolol | 2001 |
Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved beta-blockers on Chang conjunctival cells.
Topics: Adrenergic beta-Antagonists; Apoptosis; Benzalkonium Compounds; Carteolol; Cell Line; Cell Survival; Conjunctiva; DNA; Dose-Response Relationship, Drug; Glutathione; Humans; Mitochondria; Oxidative Stress; Preservatives, Pharmaceutical; Reactive Oxygen Species; Timolol | 2001 |
Ocular and retrobulbar blood flow in ocular hypertensives treated with topical timolol, betaxolol and carteolol.
Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Betaxolol; Blood Flow Velocity; Carteolol; Ciliary Arteries; Humans; Middle Aged; Ocular Hypertension; Ophthalmic Artery; Retinal Artery; Timolol | 2001 |
Short-term effect of beta-adrenoreceptor blocking agents on ocular blood flow.
Topics: Administration, Topical; Adrenergic beta-Antagonists; Animals; Betaxolol; Blood Flow Velocity; Blood Pressure; Carteolol; Choroid; Ciliary Body; Eye; Heart Rate; Intraocular Pressure; Rabbits; Random Allocation; Regional Blood Flow; Retinal Vessels; Timolol; Vascular Resistance | 2001 |
Ocular drug delivery using 20-kHz ultrasound.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Betaxolol; Carteolol; Cornea; Drug Delivery Systems; Epithelium; Models, Animal; Permeability; Rabbits; Timolol; Ultrasonics | 2002 |
Effects of commercial antiglaucoma drugs to glutamate-induced [Ca2+)]i increase in cultured neuroblastoma cells.
Topics: Animals; Antihypertensive Agents; Betaxolol; Brimonidine Tartrate; Calcium; Carteolol; Cell Death; Dose-Response Relationship, Drug; Epinephrine; Glaucoma; Glutamic Acid; Latanoprost; Mice; Neuroblastoma; Neurons; Neuroprotective Agents; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Thiazines; Thiophenes; Timolol; Tumor Cells, Cultured | 2003 |
In vitro effects of preserved or preservative-free antiglaucoma medications on human complement system.
Topics: Adrenergic beta-Antagonists; Benzalkonium Compounds; Betaxolol; Carteolol; Complement System Proteins; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Preservatives, Pharmaceutical; Prostaglandins F, Synthetic; Timolol | 2003 |
Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Carteolol; Dinoprost; Drug Therapy, Combination; Epithelium, Corneal; Female; Glaucoma, Open-Angle; Humans; Keratitis; Latanoprost; Male; Middle Aged; Ophthalmic Solutions; Prostaglandins F, Synthetic; Risk Factors; Sulfonamides; Tears; Thiophenes; Timolol | 2003 |
Measurement of inflammatory cytokines by multicytokine assay in tears of patients with glaucoma topically treated with chronic drugs.
Topics: Administration, Topical; Aged; Amides; Antihypertensive Agents; Bimatoprost; Brimonidine Tartrate; Carteolol; Case-Control Studies; Chemokines; Cloprostenol; Cytokines; Dose-Response Relationship, Immunologic; Drug Therapy, Combination; Female; Glaucoma; Humans; Intraocular Pressure; Latanoprost; Lipids; Male; Prospective Studies; Prostaglandins F, Synthetic; Quinoxalines; Sulfonamides; Tears; Thiophenes; Timolol | 2007 |
Cellular cytotoxicity of antiglaucoma drugs in cultured corneal endothelial cells.
Topics: Animals; Betaxolol; Carteolol; Cattle; Cells, Cultured; Dose-Response Relationship, Drug; Endothelial Cells; Endothelium, Corneal; Glaucoma; L-Lactate Dehydrogenase; Levobunolol; Pilocarpine; Timolol | 2007 |
Time course of changes in ocular aberrations after instillation of carteolol long-acting solution and timolol gel-forming solution.
Topics: Adrenergic beta-Antagonists; Adult; Carteolol; Eye; Female; Gels; Humans; Male; Ophthalmic Solutions; Timolol | 2011 |
Efficacy and safety of the fixed combinations of tafluprost/timolol and latanoprost/carteolol.
Topics: Animals; Antihypertensive Agents; Carteolol; Cell Line; Drug Combinations; Epithelium, Corneal; Humans; Intraocular Pressure; Latanoprost; Macaca fascicularis; Male; Prostaglandins F; Timolol | 2019 |
Cardiac and extracardiac side effects of eye drops.
Topics: Adrenergic beta-Antagonists; Atropine; Bradycardia; Carteolol; Female; Heart Diseases; Humans; Ophthalmic Solutions; Timolol; Verapamil | 2021 |
Urinary excretion patterns and potential risks of beta-blocker ophthalmic drops in sports.
Topics: Adrenergic beta-Antagonists; Carteolol; Humans; Ophthalmic Solutions; Sports; Timolol | 2023 |